Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion type Assertion NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_head.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion wasGeneratedBy ECO_0000203 NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_provenance.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion wasDerivedFrom befree-20140225 NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_provenance.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion SIO_000772 22351695 NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_provenance.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion evidence source_evidence_literature NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_provenance.
- NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548395.RA7iDPkwr_oMzCnhhl7JpKmpa8Xag1uLko9QvoJXAfscM130_provenance.